Two early CellTracks AutoPrep instrument failures, resulting in a halt to clinical specimen control, prompted the utilization of a second device to allow for continued clinical sample analysis actually if

Hoch et al. antibody-mediated autoimmune disease in which the nicotinic acetylcholine receptor (AChR) at neuromuscular junctions (NMJs) is the major autoantigen (1). AChR-specific antibodies are detected in 90% of nonimmunosuppressed